Cas no 33528-13-1 (N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide)
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide Chemical and Physical Properties
Names and Identifiers
-
- N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide
- Benzenesulfonamide,4-methyl-N-nitroso-N-(phenylmethyl)-
- N-BENZYL-N-NITROSO-P-TOLUENESULFONAMIDE
- N-benzyl-N-nitroso-4-toluenesulfonamide
- N-benzyl-N-nitroso-toluene-4-sulfonamide
- N-Benzyl-N-nitroso-toluol-4-sulfonamid
- N-benzyl-N-nitrosotosylamide
- N-nitroso-N-benzyl-p-toluenesulphonamide
- DTXSID60399508
- N-Nitroso-N-benzyl-p-toluene sulphonamide
- B3051
- N-benzyl-4-methyl-N'-oxobenzenesulfonohydrazide
- SCHEMBL3678710
- AKOS015900659
- CS-0035491
- BS-41671
- 33528-13-1
- ZXELPGWSCCGNDS-UHFFFAOYSA-N
- W12801
- MFCD00216617
- N-benzyl-N-nitroso-p-toluene-sulfonamide
-
- MDL: MFCD00216617
- Inchi: 1S/C14H14N2O3S/c1-12-7-9-14(10-8-12)20(18,19)16(15-17)11-13-5-3-2-4-6-13/h2-10H,11H2,1H3
- InChI Key: ZXELPGWSCCGNDS-UHFFFAOYSA-N
- SMILES: S(C1C=CC(C)=CC=1)(N(CC1C=CC=CC=1)N=O)(=O)=O
Computed Properties
- Exact Mass: 290.07300
- Monoisotopic Mass: 290.073
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 20
- Rotatable Bond Count: 5
- Complexity: 405
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 75.2A^2
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 2.6
Experimental Properties
- Color/Form: Not determined
- Density: 1.24
- Melting Point: 85°C(lit.)
- Boiling Point: 438.7°C at 760 mmHg
- Flash Point: 219.1°C
- Refractive Index: 1.596
- PSA: 75.19000
- LogP: 3.94810
- Solubility: Not determined
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide Security Information
-
Symbol:
- Prompt:warning
- Hazard Statement: H302+H312+H332
- Warning Statement: P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312+P362+P364-P304+P340+P312-P501
- Hazard Category Code: 20/21/22-36/37/38
- Safety Instruction: S26; S36
-
Hazardous Material Identification:
- Risk Phrases:R20/21/22; R36/37/38
- Storage Condition:0-10°C
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B3051-25g |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 98.0%(LC) | 25g |
¥1990.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B3051-5g |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 98.0%(LC) | 5g |
¥500.0 | 2022-05-30 | |
| Fluorochem | 227469-5g |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 95% | 5g |
£129.00 | 2022-02-28 | |
| Fluorochem | 227469-25g |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 95% | 25g |
£507.00 | 2022-02-28 | |
| TRC | B130290-50mg |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 50mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B130290-100mg |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 100mg |
$ 65.00 | 2022-06-07 | ||
| TRC | B130290-500mg |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide |
33528-13-1 | 500mg |
$ 115.00 | 2022-06-07 | ||
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | B3051-5G |
N-Benzyl-N-nitroso-p-toluenesulfonamide |
33528-13-1 | >98.0%(HPLC) | 5g |
¥590.00 | 2024-04-16 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | B3051-25G |
N-Benzyl-N-nitroso-p-toluenesulfonamide |
33528-13-1 | >98.0%(HPLC) | 25g |
¥2250.00 | 2024-04-16 | |
| abcr | AB251917-5 g |
N-Benzyl-N-nitroso-p-toluenesulfonamide, 98%; . |
33528-13-1 | 98% | 5g |
€194.60 | 2023-05-20 |
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide Suppliers
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide Related Literature
-
Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
Additional information on N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide
Recent Advances in the Study of N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide (CAS: 33528-13-1)
N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide (CAS: 33528-13-1) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug development, particularly as a precursor or intermediate in the synthesis of bioactive molecules. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, biological activities, and potential therapeutic applications.
One of the key areas of investigation has been the compound's role in the synthesis of nitroso compounds, which are known for their diverse biological activities. A study published in the Journal of Medicinal Chemistry (2023) highlighted the use of N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide as a versatile building block in the development of novel anticancer agents. The researchers demonstrated that the nitroso group in the compound could be leveraged to generate reactive oxygen species (ROS) in cancer cells, leading to selective cytotoxicity.
Another significant advancement was reported in a 2024 study published in Bioorganic & Medicinal Chemistry Letters. The study focused on the compound's potential as a protease inhibitor. The researchers synthesized a series of derivatives and evaluated their inhibitory activity against various proteases, including those implicated in viral infections. The results indicated that certain derivatives of N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide exhibited potent inhibitory effects, suggesting its potential as a lead compound for antiviral drug development.
In addition to its therapeutic potential, recent research has also explored the compound's chemical stability and reactivity. A 2023 study in the Journal of Organic Chemistry investigated the compound's behavior under different pH conditions and temperatures. The findings revealed that N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide exhibits remarkable stability under acidic conditions, making it a suitable candidate for use in controlled drug delivery systems.
Despite these promising findings, challenges remain in the practical application of N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide. For instance, its potential toxicity and metabolic stability in vivo require further investigation. A 2024 review article in Chemical Research in Toxicology emphasized the need for comprehensive toxicological studies to assess the safety profile of this compound and its derivatives.
In conclusion, N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide (CAS: 33528-13-1) represents a promising area of research in chemical biology and pharmaceutical sciences. Its versatility as a synthetic intermediate and its potential biological activities make it a valuable compound for further exploration. Future studies should focus on optimizing its chemical properties, evaluating its therapeutic efficacy, and addressing safety concerns to unlock its full potential in drug development.
33528-13-1 (N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide) Related Products
- 80-11-5(Diazald)
- 834-65-1(1-(3-chlorophenyl)-4-(naphthalen-1-ylmethyl)piperazine)
- 104496-42-6
- 5457-56-7( )
- 102832-11-1(Diazald-N-methyl-13C-N-methyl-d3)
- 91762-39-9(N-Benzyl-4-chlorobenzenesulfonohydrazide)
- 33469-51-1(N-Nitroso-N-propyl-p-toluenesulfonamide)
- 60858-95-9(Diazald-N-methyl-13C)
- 33469-50-0(Benzenesulfonamide, N-ethyl-4-methyl-N-nitroso-)
- 42366-72-3(Diazald-d3)